Pulmonary Emphysema clinical trials

Explore recruiting pulmonary emphysema clinical trials.

Recruiting pulmonary emphysema studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Pulmonary Emphysema trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Phase 1/2 Multicenter, Open-label Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NTLA-3001 in Participants with Alpha-1 Antitrypsin Deficiency (AATD)-Associated Lung Disease

Ireland

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

An Open-Label, Multicenter Study to Evaluate the Long-term Safety of Weekly Intravenous Alphal-Proteinase Inhibitor (Human), Modified Process 60 mg/kg in Subjects With Pulmonary Emphysema Due to Alpha1-Antitrypsin Deficiency

Sweden, France, Finland, Estonia, Denmark, Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Two Dose Regimens (60 mg/kg and 120 mg/kg) of Weekly Intravenous Alpha1-Proteinase Inhibitor (Human) in Subjects with Pulmonary Emphysema due to Alpha1-Antitrypsin Deficiency

Finland, Sweden, Poland, France, Denmark

Therapeutic confirmatory (Phase III) EU CTIS Study details

Pulmonary Emphysema trials by city

Pulmonary Emphysema clinical trials

Recruiting pulmonary emphysema studies right now

Supporting Evidence-based Responses to Emotional Needs in Emphysema

Phase III, Efficacy and Safety of "Kamada-AAT for Inhalation"

Combined Zephyr Valve System With Inter-lobar Fissure Completion for Lung Volume Reduction in Emphysema

Surgical Compared to Bronchoscopic Lung Volume Reduction in Patients With Severe Emphysema

Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3

Study to Learn About the Safety of Fazirsiran and if it Can Help People With Alpha-1 Antitrypsin Liver Disease With Mild Liver Scarring (Fibrosis)

COPD Resources, Education, and Activity Designed for You Study

Clinical-ultrasonographic Assessment of Pulmonary Emphysema

Trial Evaluating the Rate of Pneumothorax in Severe Emphysema Secondary to Endoscopic Volume Reduction With Two-stage ZEPHYR® Valves Versus Endoscopic Volume Reduction With One-stage ZEPHYR® Valves

Inter-lobar Fissure Completion in Patients With Failed Bronchoscopic Lung Volume Reduction

A Study of TSRA-196 in Adults With PiZZ Alpha-1 Antitrypsin Deficiency (AATD)

Endobronchial Silicone Valve for Patients With Emphysema

Also recruiting in Europe

Phase 1/2 Multicenter, Open-label Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NTLA-3001 in Participants with Alpha-1 Antitrypsin Deficiency (AATD)-Associated Lung Disease

An Open-Label, Multicenter Study to Evaluate the Long-term Safety of Weekly Intravenous Alphal-Proteinase Inhibitor (Human), Modified Process 60 mg/kg in Subjects With Pulmonary Emphysema Due to Alpha1-Antitrypsin Deficiency

A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Two Dose Regimens (60 mg/kg and 120 mg/kg) of Weekly Intravenous Alpha1-Proteinase Inhibitor (Human) in Subjects with Pulmonary Emphysema due to Alpha1-Antitrypsin Deficiency

Pulmonary Emphysema trials by city

Other conditions